Last reviewed · How we verify

NCT04898413

Group-based Acceptance and Commitment Therapy for Family Caregivers of People With Dementia in Japan

Completed NA Last updated 20 March 2025
What this trial tests

NA trial testing Group-based acceptance and commitment therapy (ACT) in Dementia in 15 participants. Completed in 15 March 2025.

Timeline
1 June 2021
Primary endpoint
15 March 2025
15 March 2025

Quick facts

Lead sponsorMeiji Gakuin University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment15
Start date1 June 2021
Primary completion15 March 2025
Estimated completion15 March 2025
Sites1 location across Japan

Drugs / interventions tested

Conditions studied

Sponsor

Meiji Gakuin University

Who can join

20 and older, any sex, with Dementia or Family Caregivers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Along with more people worldwide having dementia, the number of people with dementia and their family caregivers have increased in Japan. However, psychological support for family caregivers of people with dementia is still limited in Japan. The purpose of this pilot study is to examine feasibility and preliminary efficacy of a group-based acceptance and commitment therapy (ACT) for family caregivers of people with dementia in Japan compared to a group-based cognitive behavior therapy (CBT). This study also preliminarily examines the efficacy of combining psychological intervention for family caregivers (group-based ACT/CBT) with psychological intervention for their care recipients (group-based reminiscence therapy).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Dementia

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04898413.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing